Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasburicase PK in Leukemia/Lymphoma at Risk of TLS
NCT00360438Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2006
- Primary completion
- Apr 2007
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of rasburicase in tumor lysis syndrome (TLS), sponsored by University of Texas MD Anderson Cancer Center. Started Jul 2006; status: completed.
02
Drugs
rasburicase
03
Conditions
tumor lysis syndrome (TLS)
Beyond the preview
Go deeper on NCT00360438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360438.